5HT3 antagonists for prophylaxis of postoperative nausea and vomiting in breast surgery: a meta-analysis.


BACKGROUND Postoperative nausea and vomiting (PONV) are distressing adverse events following breast cancer surgery with an incidence of up to 80%. 5HT 3 antagonists are commonly employed as drugs of first choice for PONV although there is no clear evidence favoring one pharmacological approach over another. AIMS The objective of this meta-analysis is to… (More)


  • Presentations referencing similar topics